Latest News

FDA SEND 3.1 Mandate Goes Into Effect

Scope of SEND Widens to Include Support for Cardiovascular and Respiratory Studies

CONSHOHOCKEN, PA – March 15, 2019 - - Instem, a leading provider of IT solutions to the global life sciences market, announced today that the next major milestone in the FDA’s adoption of SEND (Standard for Exchange of Nonclinical Data) came into force today. 


Instem to Showcase Deep RIM Capabilities at DIA’s Upcoming RSIDM Exhibition

February 7, 2019 - Instem to Present Single-Place-of-Truth™ Approach for Regulatory Affairs Professionals


Instem’s Genetox Software Solution Complements Litron’s State-of-the-Art Genetic Toxicology Testing Methods

February 05, 2019 - Instem Reports that Leading R&D Organizations are Deploying Cyto Study Manager & Cutting-Edge Flow-Cytometric Regulatory Genetox Testing Techniques


Instem Reports Strong Demand for SEND Data Visualization Software in Preclinical Market

January 29, 2019 - Instem is pleased to announce increased demand for its SEND Explorer® software solution.


Instem Reports Increased Market Demand for KnowledgeScan Target Safety Assessment Service

December 17, 2018 - Pioneering Service Delivers Comprehensive Insight into Biological Target Profiling


View all news

 

 

GTA Annual Meeting

May 8 - 10, 2019

John M. Clayton Hall Conference Center, University of Delaware

Visit Conference Site


47th Annual EEMGS Meeting

May 19 - 23, 2019

Rennes, France

Visit Conference Site


Annual Meeting of the Chinese Society of Toxicology

June 22 - 24, 2019

Wuhan, Hubei Province

Visit Conference Site

View all events